Medicis, Perrigo Settle Fight Over Dermatitis Drug

Law360, New York (April 15, 2009, 12:00 AM EDT) -- Medicis Pharmaceutical Corp. and Perrigo Israel Pharmaceuticals Ltd. have resolved a patent suit over Medicis’ steroid skin cream Vanos, which is used to treat dermatological disorders such as psoriasis and dermatitis.

Scottsdale, Ariz.-based Medicis announced the licensing and settlement agreement in a filing made to the U.S. Securities and Exchange Commission on Tuesday.

The agreement allows Perrigo to market a generic version of Vanos and ends the lawsuit, which was filed by Medicis in the U.S. District Court for the Western District of Michigan.

Under the...
To view the full article, register now.